Bifidobacterium longum infantis Completed Phase 3 Trials for Irritable Bowel Syndrome (IBS) Treatment

Indications	Status	Purpose	Phase
DBCOND0030069 (Irritable Bowel Syndrome (IBS))	Completed	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT00135031	Efficacy of an Encapsulated Probiotic Bifidobacterium Infantis 35624 in Irritable Bowel Syndrome	Bifidobacterium longum infantis (DB14222)